Transglutaminase 2 accelerates vascular calcification in chronic kidney disease

American Journal of Nephrology

Volumn 37, Issue 3, 2013, Pages 191-198

  Chen, Neal X ^a   O'Neill, Kalisha ^a   Chen, Xianming ^a   Kiattisunthorn, Kraiwiporn ^c   Gattone, Vincent H ^a   Moe, Sharon M ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Chronic kidney disease; Extracellular matrix cell interaction; Vascular calcification

Indexed keywords

ALKALINE PHOSPHATASE; COLLAGEN TYPE 1; CYSTAMINE; ENZYME INHIBITOR; FIBRONECTIN; PHOSPHORUS; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; Z 006;

ANIMAL CELL; ANIMAL TISSUE; ARTERY CALCIFICATION; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; ENZYME ACTIVITY; EX VIVO STUDY; EXTRACELLULAR MATRIX; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; THORACIC AORTA; VASCULAR RING; VASCULAR SMOOTH MUSCLE; ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD VESSEL CALCIFICATION; CROSS LINKING; DISEASE COURSE; PHOSPHATE INTAKE;

ANIMALS; AORTA; CASE-CONTROL STUDIES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EXOSOMES; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; GTP-BINDING PROTEINS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RATS; RENAL INSUFFICIENCY, CHRONIC; TRANSGLUTAMINASES; VASCULAR CALCIFICATION;

EID: 84874606745     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000347031     Document Type: Article

References (28)

1. Moe SM, Chen NX: Mechanisms of vascular calcification in chronic kidney disease. J Am Soc Nephrol 2008; 19: 213-216.
2. Moe SM, Chen NX: Pathophysiology of vascular calcification in chronic kidney disease. Circ Res 2004; 95: 560-567.
3. Chen NX, O'Neill KD, Chen X, Moe SM: Annexin-mediated matrix vesicle calcification in vascular smooth muscle cells. J Bone Miner Res 2008; 23: 1798-1805.
4. Chen NX, Kircelli F, O'Neill KD, Chen X, Moe SM: Verapamil inhibits calcification and matrix vesicle activity of bovine vascular smooth muscle cells. Kidney Int 2010; 77: 436-442.
5. Chen NX, Chen X, O'Neill KD, Atkinson SJ, Moe SM: RhoA/Rho kinase (ROCK) alters fetuin-A uptake and regulates the calcification in bovine vascular smooth muscle cells (BVSMC). Am J Physiol Renal Physiol 2010; 299:F674-F680.
6. Bakker EN, Pistea A, VanBavel E: Transglutaminases in vascular biology: relevance for vascular remodeling and atherosclerosis. J Vasc Res 2008; 45: 271-278.
7. Al-Jallad HF, Nakano Y, Chen JL, McMillan E, Lefebvre C, Kaartinen MT: Transglutaminase activity regulates osteoblast differentiation and matrix mineralization in MC3T3-E1 osteoblast cultures. Matrix Biol 2006; 25: 135-148.
8. Johnson KA, Polewski M, Terkeltaub RA: Transglutaminase 2 is central to induction of the arterial calcification program by smooth muscle cells. Circ Res 2008; 102: 529-537.
9. Chen NX, O'Neill KD, Duan D, Moe SM: Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells. Kidney Int 2002; 62: 1724-1731.
10. Schaertl S, Prime M, Wityak J, Dominguez C, Munoz-Sanjuan I, Pacifici RE, Courtney S, Scheel A, Macdonald D: A profiling platform for the characterization of transglutaminase 2 (TG2) inhibitors. J Biomol Screen 2010; 15: 478-487.
11. Verhaar R, Jongenelen CA, Gerard M, Baekelandt V, Van Dam AM, Wilhelmus MM, Drukarch B: Blockade of enzyme activity inhibits tissue transglutaminase- mediated transamidation of alpha-synuclein in a cellular model of Parkinson's disease. Neurochem Int 2011; 58: 785-793.
12. Forsprecher J, Wang Z, Nelea V, Kaartinen MT: Enhanced osteoblast adhesion on transglutaminase 2-crosslinked fibronectin. Amino Acids 2009; 36: 747-753.
13. Lomashvili KA, Cobbs S, Hennigar RA, Hardcastle KI, O'Neill WC: Phosphate-induced vascular calcification: role of pyrophosphate and osteopontin. J Am Soc Nephrol 2004; 15: 1392-1401.
14. Lorand L, Graham RM: Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 2003; 4: 140-156.
15. Lai TS, Hausladen A, Slaughter TF, Eu JP, Stamler JS, Greenberg CS: Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase. Biochemistry 2001; 40: 4904-4910.
16. Fox JH, Barber DS, Singh B, Zucker B, Swindell MK, Norflus F, Buzescu R, Chopra R, Ferrante RJ, Kazantsev A, Hersch SM: Cystamine increases L-cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation. J Neurochem 2004; 91: 413-422.
17. Takano K, Shiraiwa K, Moriyama M, Nakamura Y: Transglutaminase 2 expression induced by lipopolysaccharide stimulation together with NO synthase induction in cultured astrocytes. Neurochem Int 2010; 57: 812-818.
18. Chen NX, Moe SM: Vascular calcification: pathophysiology and risk factors. Curr Hypertens Rep 2012; 14: 228-237.
19. Munezane T, Hasegawa T, Suritala, Tanaka A, Okada K, Okita Y: Activation of transglutaminase type 2 for aortic wall protection in a rat abdominal aortic aneurysm formation. J Vasc Surg 2010; 52: 967-974.
20. Kaartinen MT, El-Maadawy S, Rasanen NH, McKee MD: Tissue transglutaminase and its substrates in bone. J Bone Miner Res 2002; 17: 2161-2173.
21. Forsprecher J, Wang Z, Goldberg HA, Kaartinen MT: Transglutaminase- mediated oligomerization promotes osteoblast adhesive properties of osteopontin and bone sialoprotein. Cell Adh Migr 2011; 5: 65-72.
22. Matlung HL, Groen HC, de Vos J, van Walsum T, van der Lugt A, Niessen WJ, Wentzel JJ, Vanbavel E, Bakker EN: Calcification locates to transglutaminases in advanced human atherosclerotic lesions. Am J Pathol 2009; 175: 1374-1379.
23. Spurlin TA, Bhadriraju K, Chung KH, Tona A, Plant AL: The treatment of collagen fibrils by tissue transglutaminase to promote vascular smooth muscle cell contractile signaling. Biomaterials 2009; 30: 5486-5496.
24. Guerin AP, London GM, Marchais SJ, Metivier F: Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrology, Dialysis, Transplantation 2000; 15: 1014-1021.
25. Chen NX, O'Neill KD, Chen X, Kiattisunthorn K, Gattone VH, Moe SM: Activation of arterial matrix metalloproteinases leads to vascular calcification in chronic kidney disease. Am J Nephrol 2011; 34: 211-219.
26. Kapustin AN, Davies JD, Reynolds JL, Mc-Nair R, Jones GT, Sidibe A, Schurgers LJ, Skepper JN, Proudfoot D, Mayr M, Shanahan CM: Calcium regulates key components of vascular smooth muscle cell-derived matrix vesicles to enhance mineralization. Circ Res 2011; 109:e1-e12.
27. Akimov SS, Krylov D, Fleischman LF, Belkin AM: Tissue transglutaminase is an integrinbinding adhesion coreceptor for fibronectin. J Cell Biol 2000; 148: 825-838.
28. Janiak A, Zemskov EA, Belkin AM: Cell surface transglutaminase promotes RhoA activation via integrin clustering and suppression of the Src-p190RhoGAP signaling pathway. Mol Biol Cell 2006; 17: 1606-1619.